Views

Illuminating the IRA: Key Questions from the First Round of MFP Negotiations
Delve into our comprehensive review of CMS's first round of maximum fair price negotiations under the Inflation Reduction Act. Uncover the answers to three critical questions about patient perspectives, therapeutic alternatives, and generic inclusion that could reshape the future of medication pricing.
View Jan 21, 2025